{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:45:16Z","timestamp":1777506316213,"version":"3.51.4"},"reference-count":34,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473087"],"award-info":[{"award-number":["81473087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872752"],"award-info":[{"award-number":["81872752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A series of saccharide-modified thiadiazole sulfonamide derivatives has been designed and synthesized by the \u201ctail approach\u201d and evaluated for inhibitory activity against carbonic anhydrases II, IX, and XII. Most of the compounds showed high topological polar surface area (TPSA) values and excellent enzyme inhibitory activity. The impacts of some compounds on the viability of HT-29, MDA-MB-231, and MG-63 human cancer cell lines were examined under both normoxic and hypoxic conditions, and they showed certain inhibitory effects on cell viability. Moreover, it was found that the series of compounds had the ability to raise the pH of the tumor cell microenvironment. All the results proved that saccharide-modified thiadiazole sulfonamides have important research prospects for the development of CA IX inhibitors.<\/jats:p>","DOI":"10.3390\/ijms22115482","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T23:58:05Z","timestamp":1621814285000},"page":"5482","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives"],"prefix":"10.3390","volume":"22","author":[{"given":"Zuo-Peng","family":"Zhang","sequence":"first","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Bin","family":"Han","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Sheng","family":"Su","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-1944","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Sheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Angeli, A., Carta, F., Nocentini, A., Winum, J.Y., Zalubovskis, R., Akdemir, A., Onnis, V., Eldehna, W.M., Capasso, C., and De Simone, G. (2020). Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites, 10.","DOI":"10.3390\/metabo10100412"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Winum, J.Y., and Colinas, P. (2015). Chapter 21-Carbonic Anhydrases as Esterases and Their Biotechnological Applications. CARBONIC Anhydrases as Biocatalysts, Elsevier.","DOI":"10.1016\/B978-0-444-63258-6.00021-4"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/acs.jmedchem.8b00420","article-title":"Discovery of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs-CAIs) for the management of rheumatoid arthritis","volume":"61","author":"Akgul","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13064","DOI":"10.1021\/acs.jmedchem.0c01390","article-title":"Structural basis of nanomolar inhibition of tumor-associated carbonic anhydrase IX: X-ray crystallographic and inhibition study of lipophilic inhibitors with acetazolamide backbone","volume":"63","author":"Andring","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ali, M., Bozdag, M., Farooq, U., Angeli, A., Carta, F., Berto, P., Zanotti, G., and Supuran, C.T. (2020). Benzylaminoethyureido-tailed benzenesulfonamides: Design, synthesis, kinetic and X-ray Investigations on human carbonic anhydrases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072560"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhang, Z.P., Yin, Z.F., Li, J.Y., Wang, Z.P., Wu, Q.J., Wang, J., Liu, Y., and Cheng, M.S. (2019). Synthesis, molecular docking analysis, and carbonic anhydrase inhibitory evaluations of benzenesulfonamide derivatives containing thiazolidinone. Molecules, 24.","DOI":"10.3390\/molecules24132418"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: Role in pH control and cancer","volume":"8","author":"Mam","year":"2018","journal-title":"Metabolites"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Supuran, C.T. (2017). Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites, 7.","DOI":"10.3390\/metabo7030048"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41416-018-0216-5","article-title":"Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo","volume":"119","author":"Lee","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1021\/acsomega.0c06153","article-title":"Predicting isoform-selective carbonic anhydrase inhibitors via machine learning and rationalizing structural features important for selectivity","volume":"6","author":"Galati","year":"2021","journal-title":"ACS Omega"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Strapcova, S., Takacova, M., Csaderova, L., Martinelli, P., Lukacikova, L., Gal, V., Kopacek, J., and Svastova, E. (2020). Clinical and pre-clinical evidence of carbonic anhydrase IX in pancreatic cancer and its high expression in pre-cancerous lesions. Cancers, 12.","DOI":"10.3390\/cancers12082005"},{"key":"ref_14","unstructured":"(2020, April 10). A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03450018."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: Improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10637-009-9255-3","article-title":"Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity","volume":"28","author":"Nakamura","year":"2010","journal-title":"Investig. New Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1134\/S1070363220090182","article-title":"Synthesis and anticancer activity of new pyridine-thiophene and pyridine-furan hybrid compounds, their sugar hydrazone, and glycosyl derivatives","volume":"90","author":"Khalaf","year":"2020","journal-title":"Russ. J. Gen. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/15257770.2020.1736300","article-title":"Synthesis of new uracil derivatives and their sugar hydrazones with potent antimicrobial, antioxidant and anticancer activities","volume":"39","author":"Nassar","year":"2020","journal-title":"Nucleos. Nucleot. Nucl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1080\/14756366.2020.1763331","article-title":"Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity","volume":"35","author":"Sartini","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/acsami.7b16723","article-title":"Sulfonate groups and saccharides as essential structural elements in heparin-mimicking polymers used as surface modifiers: Optimization of relative contents for anti-thrombogenic properties","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","article-title":"Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site","volume":"132","author":"Hou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","article-title":"4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles","volume":"61","author":"Nocentini","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104204","DOI":"10.1016\/j.bioorg.2020.104204","article-title":"Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolarpotent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII","volume":"103","author":"Akocak","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.steroids.2013.11.022","article-title":"Click chemistry inspired highly facile synthesis of triazolyl ethisterone glycoconjugates","volume":"80","author":"Kumar","year":"2014","journal-title":"Steroids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/molecules22050785","article-title":"Design, synthesis, molecular docking analysis, and carbonic anhydrase IX inhibitory evaluations of novel N-Substituted-\u03b2-d-glucosamine derivatives that incorporate benzenesulfonamides","volume":"22","author":"Li","year":"2017","journal-title":"Molecules"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Boil. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/ci500209e","article-title":"AutoDock4Zn: An improved autodock force field for small-molecule docking to zinc metalloproteins","volume":"54","author":"Diogo","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref_34","unstructured":"(2008). Discovery Studio User Manual, Accelrys Inc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/5482\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:06:11Z","timestamp":1760162771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/5482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,22]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22115482"],"URL":"https:\/\/doi.org\/10.3390\/ijms22115482","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,22]]}}}